|
Market Cap (2-Jul) $356,619,552 (530th) |
Close (30-Jun) $0.315 |
Volume (30-Jun) 2,012,212 |
Shortsold (19-Jun) 27,150,697 (1.86%) (138th) |
|
52w High $0.415 |
52w Low $0.223 |
P/E 7.50 |
EPS -0.03 |
IMM released this announcement to the ASX on 4 June 2021, 16:17. The announcement is marked as price sensitive, and is 5 page(s) in length and 311.58kb in size.
You can view all announcements from IMM and see how they appear on a price chart on the announcements page.
At the date of this announcement, IMM was 0.246% short sold according to ASIC data. It was ranked the 350th most shorted stock on the ASX. It is now ranked as the 138th most shorted stock on the ASX with 1.859% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from IMM | |
|---|---|
| Application for quotation of securities - IMM | 29 June 2023, 10:09 |
| US patent granted for Efti with PD-1 pathway inhibitor | 27 June 2023, 14:37 |
| Immutep completes underwritten retail entitlement offer | 27 June 2023, 8:16 |
| Immutep Reports Positive Data from its TACTI-002 ph 2 trial | 4 June 2021, 16:17 |
| Immutep Reports Positive Final Data from INSIGHT-004 trial | 4 June 2021, 16:14 |
| Immutep granted European patent for its LAG-3 candidate Efti | 2 June 2021, 11:13 |
| Immutep enters New Collaboration with Merck KGaA for Efti | 1 June 2021, 8:20 |
You must be logged in to post a reply.
